Top

Published in:

01-01-2016 | Original Contribution

Melatonin attenuates sepsis-induced cardiac dysfunction via a PI3K/Akt-dependent mechanism

Authors: Rui An, Lei Zhao, Cong Xi, Haixun Li, Guohong Shen, Haixiao Liu, Shumiao Zhang, Lijun Sun

Published in: Basic Research in Cardiology | Issue 1/2016

Abstract

Myocardial dysfunction is an important manifestation of sepsis. Previous studies suggest that melatonin is protective against sepsis. In addition, activation of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway has been reported to be beneficial in sepsis. However, the role of PI3K/Akt signaling in the protective effect of melatonin against sepsis-induced myocardial dysfunction remains unclear. Here, LY294002, a PI3K inhibitor, was used to investigate the role of PI3K/Akt signaling in mediating the effects of melatonin on sepsis-induced myocardial injury. Cecal ligation and puncture (CLP) surgery was used to establish a rat model of sepsis. Melatonin was administrated to rats intraperitoneally (30 mg/kg). The survival rate, measures of myocardial injury and cardiac performance, serum lactate dehydrogenase level, inflammatory cytokine levels, oxidative stress level, and the extent of myocardial apoptosis were assessed. The results suggest that melatonin administration after CLP surgery improved survival rates and cardiac function, attenuated myocardial injury and apoptosis, and decreased the serum lactate dehydrogenase level. Melatonin decreased the production of the inflammatory cytokines TNF-α, IL-1β, and HMGB1, increased anti-oxidant enzyme activity, and decreased the expression of markers of oxidative damage. Levels of phosphorylated Akt (p-Akt), unphosphorylated Akt (Akt), Bcl-2, and Bax were measured by Western blot. Melatonin increased p-Akt levels, which suggests Akt pathway activation. Melatonin induced higher Bcl-2 expression and lower Bax expression, suggesting inhibition of apoptosis. All protective effects of melatonin were abolished by LY294002, the PI3K inhibitor. In conclusion, our results demonstrate that melatonin mitigates myocardial injury in sepsis via PI3K/Akt signaling activation.

Adi N, Mash DC, Ali Y, Singer C, Shehadeh L, Papapetropoulos S (2010) Melatonin MT1 and MT2 receptor expression in Parkinson’s disease. Med Sci Monit 16:BR61–BR67PubMed

Agil A, Reiter RJ, Jimenez-Aranda A, Iban-Arias R, Navarro-Alarcon M, Marchal JA, Adem A, Fernandez-Vazquez G (2013) Melatonin ameliorates low-grade inflammation and oxidative stress in young Zucker diabetic fatty rats. J Pineal Res 54:381–388. doi:10.1111/jpi.12012 PubMed

Ali T, Kim MO (2015) Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3beta pathway in the mouse hippocampus. J Pineal Res. doi:10.1111/jpi.12238

Amin AH, El-Missiry MA, Othman AI (2015) Melatonin ameliorates metabolic risk factors, modulates apoptotic proteins, and protects the rat heart against diabetes-induced apoptosis. Eur J Pharmacol 747:166–173. doi:10.1016/j.ejphar.2014.12.002 PubMedCrossRef

Andersson U, Tracey KJ (2003) HMGB1 in sepsis. Scand J Infect Dis 35:577–584PubMedCrossRef

Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365:63–78. doi:10.1016/S0140-6736(04)17667-8 PubMedCrossRef

Annane D, Sharshar T (2015) Cognitive decline after sepsis. Lancet Respir Med 3:61–69. doi:10.1016/S2213-2600(14)70246-2 PubMedCrossRef

Antonucci E, Fiaccadori E, Donadello K, Taccone FS, Franchi F, Scolletta S (2014) Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment. J Crit Care 29:500–511. doi:10.1016/j.jcrc.2014.03.028 PubMedCrossRef

Belosjorow S, Schulz R, Dorge H, Schade FU, Heusch G (1999) Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits. Am J Physiol 277:H2470–H2475PubMed

10.

Benitez-King G (2006) Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 40:1–9. doi:10.1111/j.1600-079X.2005.00282.x PubMedCrossRef

11.

Benitez-King G, Anton-Tay F (1993) Calmodulin mediates melatonin cytoskeletal effects. Experientia 49:635–641PubMedCrossRef

12.

Bommhardt U, Chang KC, Swanson PE, Wagner TH, Tinsley KW, Karl IE, Hotchkiss RS (2004) Akt decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol 172:7583–7591PubMedCrossRef

13.

Bondor CI, Potra AR, Moldovan D, Rusu CC, Ciorba Pop M, Muresan A, Vladutiu DS, Kacso IM (2015) Relationship of adiponectin to markers of oxidative stress in type 2 diabetic patients: influence of incipient diabetes-associated kidney disease. Int Urol Nephrol. doi:10.1007/s11255-015-1004-2

14.

Bonnefond A, Clement N, Fawcett K, Yengo L, Vaillant E, Guillaume JL, Dechaume A, Payne F, Roussel R, Czernichow S, Hercberg S, Hadjadj S, Balkau B, Marre M, Lantieri O, Langenberg C, Bouatia-Naji N, Meta-Analysis of G, Insulin-Related Traits C, Charpentier G, Vaxillaire M, Rocheleau G, Wareham NJ, Sladek R, McCarthy MI, Dina C, Barroso I, Jockers R, Froguel P (2012) Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 44:297–301. doi:10.1038/ng.1053 PubMedPubMedCentralCrossRef

15.

Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219–223. doi:10.1016/S0140-6736(02)09459-X PubMedCrossRef

16.

Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655–1657. doi:10.1126/science.296.5573.1655 PubMedCrossRef

17.

Chandra J, Samali A, Orrenius S (2000) Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29:323–333PubMedCrossRef

18.

Chen G, Zhao J, Yin Y, Wang B, Liu Q, Li P, Zhao L, Zhou H (2014) C-type natriuretic peptide attenuates LPS-induced endothelial activation: involvement of p38, Akt, and NF-kappaB pathways. Amino Acids 46:2653–2663. doi:10.1007/s00726-014-1816-x PubMedCrossRef

19.

Chen HH, Lin KC, Wallace CG, Chen YT, Yang CC, Leu S, Chen YC, Sun CK, Tsai TH, Chen YL, Chung SY, Chang CL, Yip HK (2014) Additional benefit of combined therapy with melatonin and apoptotic adipose-derived mesenchymal stem cell against sepsis-induced kidney injury. J Pineal Res 57:16–32. doi:10.1111/jpi.12140 PubMedCrossRef

20.

Cohen MV, Yang XM, Downey JM (2007) The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115:1895–1903. doi:10.1161/CIRCULATIONAHA.106.675710 PubMedCrossRef

21.

Court O, Kumar A, Parrillo JE, Kumar A (2002) Clinical review: myocardial depression in sepsis and septic shock. Crit Care 6:500–508PubMedPubMedCentralCrossRef

22.

Crouser ED (2004) Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion 4:729–741. doi:10.1016/j.mito.2004.07.023 PubMedCrossRef

23.

Cuello F, Shankar-Hari M, Mayr U, Yin X, Marshall M, Suna G, Willeit P, Langley SR, Jayawardhana T, Zeller T, Terblanche M, Shah AM, Mayr M (2014) Redox state of pentraxin 3 as a novel biomarker for resolution of inflammation and survival in sepsis. Mol Cell Proteomics 13:2545–2557. doi:10.1074/mcp.M114.039446 PubMedPubMedCentralCrossRef

24.

Dai X, Zeng Z, Fu C, Zhang S, Cai Y, Chen Z (2015) Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury. Crit Care 19:223. doi:10.1186/s13054-015-0941-6 PubMedPubMedCentralCrossRef

25.

Ekelof SV, Halladin NL, Jensen SE, Zaremba T, Aaroe J, Kjaergaard B, Simonsen CW, Rosenberg J, Gogenur I (2014) Effects of intracoronary melatonin on ischemia-reperfusion injury in ST-elevation myocardial infarction. Heart Vessels. doi:10.1007/s00380-014-0589-1 PubMed

26.

Ekmekcioglu C, Haslmayer P, Philipp C, Mehrabi MR, Glogar HD, Grimm M, Leibetseder VJ, Thalhammer T, Marktl W (2001) Expression of the MT1 melatonin receptor subtype in human coronary arteries. J Recept Signal Transduct Res 21:85–91. doi:10.1081/RRS-100107144 PubMedCrossRef

27.

Ersahin C, Masana MI, Dubocovich ML (2002) Constitutively active melatonin MT(1) receptors in male rat caudal arteries. Eur J Pharmacol 439:171–172PubMedCrossRef

28.

Faria JA, Kinote A, Ignacio-Souza LM, de Araujo TM, Razolli DS, Doneda DL, Paschoal LB, Lellis-Santos C, Bertolini GL, Velloso LA, Bordin S, Anhe GF (2013) Melatonin acts through MT1/MT2 receptors to activate hypothalamic Akt and suppress hepatic gluconeogenesis in rats. Am J Physiol Endocrinol Metab 305:E230–E242. doi:10.1152/ajpendo.00094.2013 PubMedCrossRef

29.

Fink T, Glas M, Wolf A, Kleber A, Reus E, Wolff M, Kiefer D, Wolf B, Rensing H, Volk T, Mathes AM (2014) Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis. Crit Care Med 42:e22–e31. doi:10.1097/CCM.0b013e3182a63e2b PubMedCrossRef

30.

Fruman DA, Cantley LC (2002) Phosphoinositide 3-kinase in immunological systems. Semin Immunol 14:7–18. doi:10.1006/smim.2001.0337 PubMedCrossRef

31.

Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K (2000) Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101:660–667PubMedPubMedCentralCrossRef

32.

Gamkrelidze M, Intskirveli N, Vardosanidze K, Goliadze L, Chikhladze K, Ratiani L (2014) Myocardial dysfunction during septic shock (review). Georgian Med News 237:40–46PubMed

33.

Gao M, Ha T, Zhang X, Wang X, Liu L, Kalbfleisch J, Singh K, Williams D, Li C (2013) The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling. J Infect Dis 207:1471–1479. doi:10.1093/infdis/jit036 PubMedPubMedCentralCrossRef

34.

Garcia JA, Volt H, Venegas C, Doerrier C, Escames G, Lopez LC, Acuna-Castroviejo D (2015) Disruption of the NF-kappaB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-alpha and blocks the septic response in mice. FASEB J. doi:10.1096/fj.15-273656

35.

Garcia JJ, Lopez-Pingarron L, Almeida-Souza P, Tres A, Escudero P, Garcia-Gil FA, Tan DX, Reiter RJ, Ramirez JM, Bernal-Perez M (2014) Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J Pineal Res 56:225–237. doi:10.1111/jpi.12128 PubMedCrossRef

36.

Gogenur I, Kucukakin B, Panduro Jensen L, Reiter RJ, Rosenberg J (2014) Melatonin reduces cardiac morbidity and markers of myocardial ischemia after elective abdominal aortic aneurism repair: a randomized, placebo-controlled, clinical trial. J Pineal Res 57:10–15. doi:10.1111/jpi.12138 PubMedCrossRef

37.

Gottlieb RA (2003) Mitochondrial signaling in apoptosis: mitochondrial daggers to the breaking heart. Basic Res Cardiol 98:242–249. doi:10.1007/s00395-003-0404-0 PubMed

38.

Gyurkovska V, Ivanovska N (2015) Tyrosine kinase inhibitor tyrphostin AG490 reduces liver injury in LPS-induced shock. Eur J Pharmacol 751:118–126. doi:10.1016/j.ejphar.2015.01.045 PubMedCrossRef

39.

Hardeland R (2009) Melatonin: signaling mechanisms of a pleiotropic agent. BioFactors 35:183–192. doi:10.1002/biof.23 PubMedCrossRef

40.

Harris HE, Andersson U, Pisetsky DS (2012) HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8:195–202. doi:10.1038/nrrheum.2011.222 PubMedCrossRef

41.

Hernandez-Resendiz S, Palma-Flores C, De Los Santos S, Roman-Anguiano NG, Flores M, de la Pena A, Flores PL, Fernandez GJ, Coral-Vazquez RM, Zazueta C (2015) Reduction of no-reflow and reperfusion injury with the synthetic 17beta-aminoestrogen compound Prolame is associated with PI3K/Akt/eNOS signaling cascade. Basic Res Cardiol 110:1. doi:10.1007/s00395-015-0464-y PubMedCrossRef

42.

Hevia D, Gonzalez-Menendez P, Quiros-Gonzalez I, Miar A, Rodriguez-Garcia A, Tan DX, Reiter RJ, Mayo JC, Sainz RM (2015) Melatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer. J Pineal Res 58:234–250. doi:10.1111/jpi.12210 PubMedCrossRef

43.

Hill SM, Belancio VP, Dauchy RT, Xiang S, Brimer S, Mao L, Hauch A, Lundberg P, Summers W, Yuan L, Frasch T, Blask DE (2015) Melatonin: an inhibitor of breast cancer. Endocr Relat Cancer. doi:10.1530/ERC-15-0030 PubMedPubMedCentral

44.

Hirano Y, Aziz M, Yang WL, Wang Z, Zhou M, Ochani M, Khader A, Wang P (2015) Neutralization of osteopontin attenuates neutrophil migration in sepsis-induced acute lung injury. Crit Care 19:53. doi:10.1186/s13054-015-0782-3 PubMedPubMedCentralCrossRef

45.

Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150. doi:10.1056/NEJMra021333 PubMedCrossRef

46.

Hotchkiss RS, Karl IE (1992) Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 267:1503–1510PubMedCrossRef

47.

Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27:1230–1251PubMedCrossRef

48.

Hsu JT, Kuo CJ, Chen TH, Wang F, Lin CJ, Yeh TS, Hwang TL, Jan YY (2012) Melatonin prevents hemorrhagic shock-induced liver injury in rats through an Akt-dependent HO-1 pathway. J Pineal Res 53:410–416. doi:10.1111/j.1600-079X.2012.01011.x PubMedCrossRef

49.

Jang JH, Chun JN, Godo S, Wu G, Shimokawa H, Jin CZ, Jeon JH, Kim SJ, Jin ZH, Zhang YH (2015) ROS and endothelial nitric oxide synthase (eNOS)-dependent trafficking of angiotensin II type 2 receptor begets neuronal NOS in cardiac myocytes. Basic Res Cardiol 110:21. doi:10.1007/s00395-015-0477-6 PubMedCrossRef

50.

Jezek P, Hlavata L (2005) Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 37:2478–2503. doi:10.1016/j.biocel.2005.05.013 PubMedCrossRef

51.

Jiang S, Zhu W, Li C, Zhang X, Lu T, Ding Z, Cao K, Liu L (2013) alpha-Lipoic acid attenuates LPS-induced cardiac dysfunction through a PI3K/Akt-dependent mechanism. Int Immunopharmacol 16:100–107. doi:10.1016/j.intimp.2013.03.024 PubMedCrossRef

52.

Johansson L, Snall J, Sendi P, Linner A, Thulin P, Linder A, Treutiger CJ, Norrby-Teglund A (2014) HMGB1 in severe soft tissue infections caused by Streptococcus pyogenes. Front Cell Infect Microbiol 4:4. doi:10.3389/fcimb.2014.00004 PubMedPubMedCentralCrossRef

53.

Jonassen AK, Sack MN, Mjos OD, Yellon DM (2001) Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89:1191–1198PubMedCrossRef

54.

Karbownik M, Reiter RJ (2000) Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 225:9–22PubMedCrossRef

55.

Kim TH, Kim SJ, Lee SM (2014) Stimulation of the alpha7 nicotinic acetylcholine receptor protects against sepsis by inhibiting Toll-like receptor via phosphoinositide 3-kinase activation. J Infect Dis 209:1668–1677. doi:10.1093/infdis/jit669 PubMedCrossRef

56.

Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A (2008) HMGB1: endogenous danger signaling. Mol Med 14:476–484. doi:10.2119/2008-00034.Klune PubMedPubMedCentralCrossRef

57.

Korkmaz B, Cuez T, Buharalioglu CK, Demiryurek AT, Sahan-Firat S, Sari AN, Tunctan B (2012) Contribution of MEK1/ERK1/2/iNOS pathway to oxidative stress and decreased caspase-3 activity in endotoxemic rats. Antiinflamm Antiallergy Agents Med Chem 11:243–252PubMedCrossRef

58.

Kumar A, Haery C, Parrillo JE (2000) Myocardial dysfunction in septic shock. Crit Care Clin 16:251–287PubMedCrossRef

59.

Lee I, Huttemann M (2014) Energy crisis: the role of oxidative phosphorylation in acute inflammation and sepsis. Biochim Biophys Acta 1842:1579–1586. doi:10.1016/j.bbadis.2014.05.031 PubMedPubMedCentralCrossRef

60.

Lew WY, Yasuda S, Yuan T, Hammond HK (1996) Endotoxin-induced cardiac depression is associated with decreased cardiac dihydropyridine receptors in rabbits. J Mol Cell Cardiol 28:1367–1371PubMedCrossRef

61.

Li C, Hua F, Ha T, Singh K, Lu C, Kalbfleisch J, Breuel KF, Ford T, Kao RL, Gao M, Ozment TR, Williams DL (2012) Activation of myocardial phosphoinositide-3-kinase p110alpha ameliorates cardiac dysfunction and improves survival in polymicrobial sepsis. PLoS ONE 7:e44712. doi:10.1371/journal.pone.0044712 PubMedPubMedCentralCrossRef

62.

Li L, Ling Y, Huang M, Yin T, Gou SM, Zhan NY, Xiong JX, Wu HS, Yang ZY, Wang CY (2015) Heparin inhibits the inflammatory response induced by LPS and HMGB1 by blocking the binding of HMGB1 to the surface of macrophages. Cytokine 72:36–42. doi:10.1016/j.cyto.2014.12.010 PubMedCrossRef

63.

Li P, Guo Y, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J (2015) Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis. Crit Care 19:200. doi:10.1186/s13054-015-0919-4 PubMedPubMedCentralCrossRef

64.

Li Volti G, Musumeci T, Pignatello R, Murabito P, Barbagallo I, Carbone C, Gullo A, Puglisi G (2012) Antioxidant potential of different melatonin-loaded nanomedicines in an experimental model of sepsis. Exp Biol Med (Maywood) 237:670–677. doi:10.1258/ebm.2012.011425 CrossRef

65.

Li XQ, Cao W, Li T, Zeng AG, Hao LL, Zhang XN, Mei QB (2009) Amlodipine inhibits TNF-alpha production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/Akt pathway. Int Immunopharmacol 9:1032–1041. doi:10.1016/j.intimp.2009.04.010 PubMedCrossRef

66.

Liu L, Wang P, Liang C, He D, Yu Y, Liu X (2013) Distinct effects of Nampt inhibition on mild and severe models of lipopolysaccharide-induced myocardial impairment. Int Immunopharmacol 17:342–349. doi:10.1016/j.intimp.2013.06.017 PubMedCrossRef

67.

Liu L, Xie K, Chen H, Dong X, Li Y, Yu Y, Wang G, Yu Y (2014) Inhalation of hydrogen gas attenuates brain injury in mice with cecal ligation and puncture via inhibiting neuroinflammation, oxidative stress and neuronal apoptosis. Brain Res 1589:78–92. doi:10.1016/j.brainres.2014.09.030 PubMedCrossRef

68.

Liu LF, Qin Q, Qian ZH, Shi M, Deng QC, Zhu WP, Zhang H, Tao XM, Liu Y (2014) Protective effects of melatonin on ischemia-reperfusion induced myocardial damage and hemodynamic recovery in rats. Eur Rev Med Pharmacol Sci 18:3681–3686PubMed

69.

Liu XY, Zhou XY, Hou JC, Zhu H, Wang Z, Liu JX, Zheng YQ (2015) Ginsenoside Rd promotes neurogenesis in rat brain after transient focal cerebral ischemia via activation of PI3K/Akt pathway. Acta Pharmacol Sin 36:421–428. doi:10.1038/aps.2014.156 PubMedPubMedCentralCrossRef

70.

Lorente L, Martin MM, Abreu-Gonzalez P, de la Cruz T, Ferreres J, Sole-Violan J, Labarta L, Diaz C, Jimenez A, Borreguero-Leon JM (2015) Serum melatonin levels are associated with mortality in severe septic patients. J Crit Care 30(860):e861–e866. doi:10.1016/j.jcrc.2015.03.023

71.

Lorigados CB, Ariga SK, Batista TR, Velasco IT, Soriano FG (2015) Endotoxaemic myocardial dysfunction: the role of coronary driving pressure in subendocardial perfusion. Crit Care Resusc 17:12–22PubMed

72.

Lu B, Antoine DJ, Kwan K, Lundback P, Wahamaa H, Schierbeck H, Robinson M, Van Zoelen MA, Yang H, Li J, Erlandsson-Harris H, Chavan SS, Wang H, Andersson U, Tracey KJ (2014) JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci USA 111:3068–3073. doi:10.1073/pnas.1316925111 PubMedPubMedCentralCrossRef

73.

Lyssenko V, Nagorny CL, Erdos MR, Wierup N, Jonsson A, Spegel P, Bugliani M, Saxena R, Fex M, Pulizzi N, Isomaa B, Tuomi T, Nilsson P, Kuusisto J, Tuomilehto J, Boehnke M, Altshuler D, Sundler F, Eriksson JG, Jackson AU, Laakso M, Marchetti P, Watanabe RM, Mulder H, Groop L (2009) Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 41:82–88. doi:10.1038/ng.288 PubMedPubMedCentralCrossRef

74.

Macias M, Escames G, Leon J, Coto A, Sbihi Y, Osuna A, Acuna-Castroviejo D (2003) Calreticulin-melatonin. An unexpected relationship. Eur J Biochem 270:832–840PubMedCrossRef

75.

Mao L, Lin W, Nie T, Hui X, Gao X, Li K, Ding M, Tang X, Li P, Wang Y, Xu A, Liu P, Wu D (2014) Absence of Appl2 sensitizes endotoxin shock through activation of PI3K/Akt pathway. Cell Biosci 4:60. doi:10.1186/2045-3701-4-60 PubMedPubMedCentralCrossRef

76.

Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554. doi:10.1056/NEJMoa022139 PubMedCrossRef

77.

Masana MI, Doolen S, Ersahin C, Al-Ghoul WM, Duckles SP, Dubocovich ML, Krause DN (2002) MT(2) melatonin receptors are present and functional in rat caudal artery. J Pharmacol Exp Ther 302:1295–1302PubMedCrossRef

78.

Mauriz JL, Collado PS, Veneroso C, Reiter RJ, Gonzalez-Gallego J (2013) A review of the molecular aspects of melatonin’s anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 54:1–14. doi:10.1111/j.1600-079X.2012.01014.x PubMed

79.

Melendez J, Maldonado V, Ortega A (1996) Effect of melatonin on beta-tubulin and MAP2 expression in NIE-115 cells. Neurochem Res 21:653–658PubMedCrossRef

80.

Merx MW, Weber C (2007) Sepsis and the heart. Circulation 116:793–802. doi:10.1161/CIRCULATIONAHA.106.678359 PubMedCrossRef

81.

Miki T, Miura T, Tanno M, Nishihara M, Naitoh K, Sato T, Takahashi A, Shimamoto K (2007) Impairment of cardioprotective PI3K-Akt signaling by post-infarct ventricular remodeling is compensated by an ERK-mediated pathway. Basic Res Cardiol 102:163–170. doi:10.1007/s00395-006-0622-3 PubMedCrossRef

82.

Mukherjee D, Ghosh AK, Dutta M, Mitra E, Mallick S, Saha B, Reiter RJ, Bandyopadhyay D (2015) Mechanisms of isoproterenol-induced cardiac mitochondrial damage: protective actions of melatonin. J Pineal Res 58:275–290. doi:10.1111/jpi.12213 PubMedCrossRef

83.

Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403:98–103. doi:10.1038/47513 PubMedCrossRef

84.

Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P (2001) Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med 163:218–225. doi:10.1164/ajrccm.163.1.2003109 PubMedCrossRef

85.

Ortiz F, Garcia JA, Acuna-Castroviejo D, Doerrier C, Lopez A, Venegas C, Volt H, Luna-Sanchez M, Lopez LC, Escames G (2014) The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS. J Pineal Res 56:71–81. doi:10.1111/jpi.12099 PubMedCrossRef

86.

Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227–242PubMedCrossRef

87.

Pasqua T, Filice E, Mazza R, Quintieri AM, Carmela Cerra M, Iannacone R, Melfi D, Indiveri C, Gattuso A, Angelone T (2015) Cardiac and hepatic role of r-AtHSP70: basal effects and protection against ischemic and sepsis conditions. J Cell Mol Med. doi:10.1111/jcmm.12491 PubMedPubMedCentral

88.

Penna C, Brancaccio M, Tullio F, Rubinetto C, Perrelli MG, Angotti C, Pagliaro P, Tarone G (2014) Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury. Basic Res Cardiol 109:418. doi:10.1007/s00395-014-0418-9 PubMedCrossRef

89.

Prabhu MM, Yalakala SK, Shetty R, Thakkar A, Sitapara T (2015) Prognosis of left ventricular systolic dysfunction in septic shock patients. J Clin Diagn Res 9:OC05–OC08. doi:10.7860/JCDR/2015/10812.5640 PubMedPubMedCentral

90.

Rajaram MV, Ganesan LP, Parsa KV, Butchar JP, Gunn JS, Tridandapani S (2006) Akt/Protein kinase B modulates macrophage inflammatory response to Francisella infection and confers a survival advantage in mice. J Immunol 177:6317–6324PubMedCrossRef

91.

Reiter RJ, Tan DX, Gitto E, Sainz RM, Mayo JC, Leon J, Manchester LC, Vijayalaxmi Kilic E, Kilic U (2004) Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol J Pharmacol 56:159–170PubMed

92.

Reppert SM (1997) Melatonin receptors: molecular biology of a new family of G protein-coupled receptors. J Biol Rhythms 12:528–531PubMedCrossRef

93.

Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative G (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377. doi:10.1056/NEJMoa010307 PubMedCrossRef

94.

Rudiger A, Singer M (2007) Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:1599–1608. doi:10.1097/01.CCM.0000266683.64081.02 PubMedCrossRef

95.

Sanfilippo F, Corredor C, Fletcher N, Landesberg G, Benedetto U, Foex P, Cecconi M (2015) Diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis. Intensive Care Med. doi:10.1007/s00134-015-3748-7

96.

Schmidt HB, Werdan K, Muller-Werdan U (2001) Autonomic dysfunction in the ICU patient. Curr Opin Crit Care 7:314–322PubMedCrossRef

97.

Sharshar T, Gray F, Lorin de la Grandmaison G, Hopkinson NS, Ross E, Dorandeu A, Orlikowski D, Raphael JC, Gajdos P, Annane D (2003) Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 362:1799–1805PubMedCrossRef

98.

Shim DW, Shin HJ, Han JW, Ji YE, Jang CH, Koppula S, Kang TB, Lee KH (2015) A novel synthetic derivative of melatonin, 5-hydroxy-2′-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation. Toxicol Appl Pharmacol. doi:10.1016/j.taap.2015.02.006 PubMed

99.

Siddall HK, Warrell CE, Yellon DM, Mocanu MM (2008) Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency. Basic Res Cardiol 103:560–568. doi:10.1007/s00395-008-0735-y PubMedCrossRef

100.

Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, Heusch G (2009) Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 104:15–18. doi:10.1161/CIRCRESAHA.108.186429 PubMedCrossRef

101.

Song JQ, Teng X, Cai Y, Tang CS, Qi YF (2009) Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion. Apoptosis 14:1061–1069. doi:10.1007/s10495-009-0382-2 PubMedCrossRef

102.

Stanley WC, Recchia FA, Lopaschuk GD (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85:1093–1129. doi:10.1152/physrev.00006.2004 PubMedCrossRef

103.

Steven S, Hausding M, Kroller-Schon S, Mader M, Mikhed Y, Stamm P, Zinssius E, Pfeffer A, Welschof P, Agdauletova S, Sudowe S, Li H, Oelze M, Schulz E, Klein T, Munzel T, Daiber A (2015) Gliptin and GLP-1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide-induced endotoxemia. Basic Res Cardiol 110:6. doi:10.1007/s00395-015-0465-x PubMedCrossRef

104.

Sun B, Xiao J, Sun XB, Wu Y (2013) Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling. Br J Pharmacol 168:1758–1770. doi:10.1111/bph.12063 PubMedPubMedCentralCrossRef

105.

Turner KL, Moore LJ, Todd SR, Sucher JF, Jones SA, McKinley BA, Valdivia A, Sailors RM, Moore FA (2011) Identification of cardiac dysfunction in sepsis with B-type natriuretic peptide. J Am Coll Surg 213:139–146. doi:10.1016/j.jamcollsurg.2011.03.027 (discussion 146–147) PubMedCrossRef

106.

van de Sandt AM, Windler R, Godecke A, Ohlig J, Zander S, Reinartz M, Graf J, van Faassen EE, Rassaf T, Schrader J, Kelm M, Merx MW (2013) Endothelial NOS (NOS3) impairs myocardial function in developing sepsis. Basic Res Cardiol 108:330. doi:10.1007/s00395-013-0330-8 PubMedPubMedCentralCrossRef

107.

Vanmassenhove J, Glorieux G, Lameire N, Hoste E, Dhondt A, Vanholder R, Van Biesen W (2015) Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis. BMC Nephrol 16:18. doi:10.1186/s12882-015-0003-y PubMedPubMedCentralCrossRef

108.

Vazan R, Ravingerova T (2015) Protective effect of melatonin against myocardial injury induced by epinephrine. J Physiol Biochem 71:43–49. doi:10.1007/s13105-014-0377-5 PubMedCrossRef

109.

Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251PubMedCrossRef

110.

Wang X, Liu D, Chai W, Long Y, Su L, Yang R (2014) The role of uncoupling protein-2 (UCP2) during myocardial dysfunction in a canine model of endotoxin shock. Shock. doi:10.1097/SHK.0000000000000286 PubMedCentral

111.

Whelan RS, Kaplinskiy V, Kitsis RN (2010) Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 72:19–44. doi:10.1146/annurev.physiol.010908.163111 PubMedCrossRef

112.

Williams DL, Ozment-Skelton T, Li C (2006) Modulation of the phosphoinositide 3-kinase signaling pathway alters host response to sepsis, inflammation, and ischemia/reperfusion injury. Shock 25:432–439. doi:10.1097/01.shk.0000209542.76305.55 PubMedCrossRef

113.

Wu JY, Tsou MY, Chen TH, Chen SJ, Tsao CM, Wu CC (2008) Therapeutic effects of melatonin on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats. J Pineal Res 45:106–116. doi:10.1111/j.1600-079X.2008.00567.x PubMedCrossRef

114.

Wu YH, Zhou JN, Van Heerikhuize J, Jockers R, Swaab DF (2007) Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer’s disease. Neurobiol Aging 28:1239–1247. doi:10.1016/j.neurobiolaging.2006.06.002 PubMedCrossRef

115.

Xu C, Yi C, Wang H, Bruce IC, Xia Q (2012) Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening. Shock 37:110–115. doi:10.1097/SHK.0b013e3182391831 PubMedCrossRef

116.

Yang J, Zong X, Wu G, Lin S, Feng Y, Hu J (2015) Taurine increases testicular function in aged rats by inhibiting oxidative stress and apoptosis. Amino Acids. doi:10.1007/s00726-015-1995-0

117.

Yang Y, Jiang S, Dong Y, Fan C, Zhao L, Yang X, Li J, Di S, Yue L, Liang G, Reiter RJ, Qu Y (2015) Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice. J Pineal Res 58:61–70. doi:10.1111/jpi.12193 PubMedCrossRef

118.

Yao K, Ye P, Zhang L, Tan J, Tang X, Zhang Y (2008) Epigallocatechin gallate protects against oxidative stress-induced mitochondria-dependent apoptosis in human lens epithelial cells. Mol Vis 14:217–223PubMedPubMedCentral

119.

Yeung HM, Hung MW, Lau CF, Fung ML (2015) Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. J Pineal Res 58:12–25. doi:10.1111/jpi.12190 PubMedCrossRef

120.

You W, Min X, Zhang X, Qian B, Pang S, Ding Z, Li C, Gao X, Di R, Cheng Y, Liu L (2009) Cardiac-specific expression of heat shock protein 27 attenuated endotoxin-induced cardiac dysfunction and mortality in mice through a PI3K/Akt-dependent mechanism. Shock 32:108–117. doi:10.1097/SHK.0b013e318199165d PubMedCrossRef

121.

Yu L, Sun Y, Cheng L, Jin Z, Yang Y, Zhai M, Pei H, Wang X, Zhang H, Meng Q, Zhang Y, Yu S, Duan W (2014) Melatonin receptor-mediated protection against myocardial ischemia/reperfusion injury: role of SIRT1. J Pineal Res 57:228–238. doi:10.1111/jpi.12161 PubMedCrossRef

122.

Zhang B, Liu Y, Zhang JS, Zhang XH, Chen WJ, Yin XH, Qi YF (2015) Cortistatin protects myocardium from endoplasmic reticulum stress induced apoptosis during sepsis. Mol Cell Endocrinol 406:40–48. doi:10.1016/j.mce.2015.02.016 PubMedCrossRef

123.

Zhang H, Liu D, Wang X, Chen X, Long Y, Chai W, Zhou X, Rui X, Zhang Q, Wang H, Yang Q (2013) Melatonin improved rat cardiac mitochondria and survival rate in septic heart injury. J Pineal Res 55:1–6. doi:10.1111/jpi.12033 PubMedCrossRef

124.

Zhang HM, Zhang Y (2014) Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 57:131–146. doi:10.1111/jpi.12162 PubMedCrossRef

125.

Zhang T, Lu X, Li J, Chidiac P, Sims SM, Feng Q (2012) Inhibition of Na/K-ATPase promotes myocardial tumor necrosis factor-alpha protein expression and cardiac dysfunction via calcium/mTOR signaling in endotoxemia. Basic Res Cardiol 107:254. doi:10.1007/s00395-012-0254-8 PubMedCrossRef

126.

Zhang WJ, Wei H, Hagen T, Frei B (2007) Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad Sci USA 104:4077–4082. doi:10.1073/pnas.0700305104 PubMedPubMedCentralCrossRef

127.

Zhang Z (2015) Biomarkers, diagnosis and management of sepsis-induced acute kidney injury: a narrative review. Heart Lung Vessel 7:64–73PubMedPubMedCentral

128.

Zhong J, Hwang TC, Adams HR, Rubin LJ (1997) Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs. Am J Physiol 273:H2312–H2324PubMed

129.

Zhou H, Qian J, Li C, Li J, Zhang X, Ding Z, Gao X, Han Z, Cheng Y, Liu L (2011) Attenuation of cardiac dysfunction by HSPA12B in endotoxin-induced sepsis in mice through a PI3K-dependent mechanism. Cardiovasc Res 89:109–118. doi:10.1093/cvr/cvq268 PubMedCrossRef

130.

Zweier JL, Flaherty JT, Weisfeldt ML (1987) Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 84:1404–1407PubMedPubMedCentralCrossRef

Title: Melatonin attenuates sepsis-induced cardiac dysfunction via a PI3K/Akt-dependent mechanism
Authors: Rui An
Lei Zhao
Cong Xi
Haixun Li
Guohong Shen
Haixiao Liu
Shumiao Zhang
Lijun Sun
Publication date: 01-01-2016
Publisher: Springer Berlin Heidelberg
Published in: Basic Research in Cardiology / Issue 1/2016
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-015-0526-1

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Melatonin attenuates sepsis-induced cardiac dysfunction via a PI3K/Akt-dependent mechanism

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart

Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside

Knock-out of nexilin in mice leads to dilated cardiomyopathy and endomyocardial fibroelastosis

DNA methylation in an engineered heart tissue model of cardiac hypertrophy: common signatures and effects of DNA methylation inhibitors

Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages

Prevention of adenosine A2A receptor activation diminishes beat-to-beat alternation in human atrial myocytes

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page